undamentalytics Newsletter
Sign in

Cryoport, Inc. cash flow statement

In fiscal 2025, Cryoport, Inc.'s operations generated −$8.6m of cash; it spent $16.4m on capital projects, leaving free cash flow of −$25.0m. It returned $10.0m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2011Mar 20112012Mar 20122013Mar 20132014Mar 20142015Mar 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−5−7−5−4−4−6−4−3−1−158−2−1−16−98
Depreciation and amortisation00000011210202327312826
Stock-based pay10111345179152020171010
Capital spending0000012359242239171628
Free cash flow−5−7−5−5−4−7−5−6−7−24−16−24−40−34−25−20
Free cash flow after stock pay−6−7−6−5−5−10−9−12−23−33−31−44−59−50−35−30
Share buybacks—————————0038——10—
Shares issued1250—000100280—————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: CTKB vs CYRXCYRX vs MRVICYRX vs GRALCYRX vs PACB

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Cryoport, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cryoport, Inc.